↓ Skip to main content

Metabolic comorbidities and the association with risks of recurrent metastatic disease in breast cancer survivors

Overview of attention for article published in BMC Cancer, May 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
91 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Metabolic comorbidities and the association with risks of recurrent metastatic disease in breast cancer survivors
Published in
BMC Cancer, May 2021
DOI 10.1186/s12885-021-08343-0
Pubmed ID
Authors

Sumadi Lukman Anwar, Roby Cahyono, Dayat Prabowo, Widya Surya Avanti, Lina Choridah, Ery Kus Dwianingsih, Wirsma Arif Harahap, Teguh Aryandono

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 91 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 10%
Student > Bachelor 9 10%
Other 7 8%
Researcher 5 5%
Student > Master 4 4%
Other 5 5%
Unknown 52 57%
Readers by discipline Count As %
Medicine and Dentistry 19 21%
Nursing and Health Professions 6 7%
Biochemistry, Genetics and Molecular Biology 5 5%
Computer Science 2 2%
Pharmacology, Toxicology and Pharmaceutical Science 1 1%
Other 4 4%
Unknown 54 59%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 November 2023.
All research outputs
#3,452,890
of 24,848,516 outputs
Outputs from BMC Cancer
#793
of 8,803 outputs
Outputs of similar age
#81,915
of 439,056 outputs
Outputs of similar age from BMC Cancer
#21
of 301 outputs
Altmetric has tracked 24,848,516 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,803 research outputs from this source. They receive a mean Attention Score of 4.6. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,056 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 301 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.